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Abstract
Copy number variations (CNVs), a common genomic mutation associated with various diseases, are important in research
and clinical applications. Whole genome amplification (WGA) and massively parallel sequencing have been applied to single
cell CNVs analysis, which provides new insight for the fields of biology and medicine. However, the WGA-induced bias
significantly limits sensitivity and specificity for CNVs detection. Addressing these limitations, we developed a practical
bioinformatic methodology for CNVs detection at the single cell level using low coverage massively parallel sequencing.
This method consists of GC correction for WGA-induced bias removal, binary segmentation algorithm for locating CNVs
breakpoints, and dynamic threshold determination for final signals filtering. Afterwards, we evaluated our method with
seven test samples using low coverage sequencing (4,9.5%). Four single-cell samples from peripheral blood, whose
karyotypes were confirmed by whole genome sequencing analysis, were acquired. Three other test samples derived from
blastocysts whose karyotypes were confirmed by SNP-array analysis were also recruited. The detection results for CNVs of
larger than 1 Mb were highly consistent with confirmed results reaching 99.63% sensitivity and 97.71% specificity at base-
pair level. Our study demonstrates the potential to overcome WGA-bias and to detect CNVs (.1 Mb) at the single cell level
through low coverage massively parallel sequencing. It highlights the potential for CNVs research on single cells or limited
DNA samples and may prove as a promising tool for research and clinical applications, such as pre-implantation genetic
diagnosis/screening, fetal nucleated red blood cells research and cancer heterogeneity analysis.
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Introduction
Copy number variations (CNVs) are known to be associated
with various diseases, such as 22q11.2 deletion/duplication
syndrome [1,2,3], Cri-du-Chat (5p deletion) [4] and even cancers
[5]. Rather than cell-population research, single cell analysis
provides insights into research of disease aetiology and diagnosis. It
is especially useful for cancer heterogeneity research, since it has
been shown to detect a single-nucleotide mutation that could result
in a kidney tumor [6]. It is also useful for conducting evolution
research since it has proven that CNVs plays an important role on
cell evolution [7,8]. In addition, for the clinical purposes, pre-
implantation genetic diagnosis/screening (PGD/PGS) was used
for disease scanning since 1990s [9,10,11]. This application allows
CNVs analysis of single cell isolated from polar body, blastomere
or blastocyst. Single-cell analysis may also open up new
opportunities for noninvasive prenatal genetic diagnosis by only
needing a single fetal nucleated red blood cell (NRBC) [12,13].
Whole genome amplification (WGA) and array comparative
genomic hybridization (aCGH) technology have been widely used
in CNVs analysis of single cells [14,15]. aCGH technology is based
on the differential labels of test sample and reference DNA with
fluorophores. These samples are then hybridized to array
containing oligonucleotide probes and subsequently analyzed for
fluorometric signal ratios, which allows for the calling of the copy
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number profile of discrete genomic intervals. However, there are
several limitations of WGA-based aCGH. WGA-induced biases
have been observed in previous studies [16,17,18,19,20] and can
hinder the sensitivity and specificity of CNV detection, since it has
been associated with sequence repeats, proximity to chromosome
ends [18,19,20] and GC content [18,20]. In the procedure of
WGA, GC content, in particular, can influence polymerase
processivity and DNA priming so as to lead to false CNVs signal.
This can be caused by over-amplification or under-amplification
on GC-poor or GC-rich regions [18,20]. Nowadays, massively
parallel sequencing (MPS) has become an advanced approach for
genomics research [21]. The power of whole genome sequencing
(WGS) in profiling genome copy number landscapes makes it
notably more advantageous over aCGH, as reported in previous
studies [22,23].
In this study, we developed a WGA-induced bias correction
strategy based on GC bias description using two single cells
isolated from the peripheral blood (PB) of YH, a healthy Chinese
individual with a normal karyotype. We then established a
practical bioinformatics pipeline, which detected CNVs at the
single cell level through low coverage whole genome sequencing.
GC correction to lessen WGA-induced bias, a binary segmenta-
tion algorithm for CNVs breakpoint location, and dynamic
threshold determination for final CNV signals filtering constituted
the core of this pipeline. Seven single cells isolated from PB or
blastocysts with confirmed CNV results were recruited to examine
the performance of this pipeline. Our method explores CNVs in
single cells or limited DNA, which provides a practical approach
for CNVs detection in the clinic.
Results
WGA-induced GC bias correction and pipeline
establishment
In order to observe and correct GC biases in WGA, we isolated,
amplified, and sequenced two single cells from the PB of YH, a
healthy Chinese individual with normal karyotype [24], generating
an average of 13.04 million single-end (SE) 50 bp reads of each
cell (Table 1).We defined the quotient between the reads number
of each observation window and the average reads number as
relative read number (RRN), which ideally would be equal to one
in diploid genome. By comparing the GC content and RRN, we
discovered that the RRN tended to be less than average in
genomic GC-poor (,40%) and GC-enriched (.48%) regions
(Figure 1A), implying significant amplification bias of these
regions.
Based on this discovery, we developed a weighted correction
strategy to remove the GC bias. RRN would be adjusted by a GC-
related weighting coefficient, calculated using RRN in windows
that shared same GC content (Methods and materials). After re-
normalization, the corrected relative reads number (CRN) showed
a much better uniformity of GC content, indicating a high efficacy
of the correction (Figure 1B). Also, the self-defined GC-bias index
proved that more than 99.90% of the GC biases were removed by
our strategy. (Materials and Methods, Table S1)
After GC bias correction, we employed a binary segmentation
algorithm to access higher accuracy of the localization of the
CNVs breakpoints on the chromosome. Candidate breakpoints
were obtained after initialization and the adjacent windows were
merged to localize the optimized breakpoints. Considering the
influence of different GC content on CNVs detection, we
developed a dynamic threshold determination algorithm for the
final signal filtering, which would improve the general sensitivity
and specificity of CNVs detection. Finally, we established a
comprehensive bioinformatics pipeline (Figure 2), which included
sequencing reads alignment, GC bias correction, a binary
segmentation algorithm and dynamic threshold determination
for signals filtering.
Evaluation of sensitivity and specificity
To examine our method, we isolated seven single cells from PB
and blastocysts whose karyotypes were already confirmed by
whole genome sequencing analysis or SNP-array analysis,
respectively. These karyotypes were normal, had CNVs, or had
aneuploidies. An average of about 10.92 million SE 50 bp reads
were obtained for each single-cell samples and mapped to the
human reference genome (HG18, NCBI Build36) using SOAP2
[25] (Table 1). The coverage of those sequencing reads in the
genome ranged from 4.0% to 9.5%. All these single cell samples
had received CNV analysis using the standard pipeline described
above (Figure 2), and were used to evaluate the sensitivity and
specificity of the method.
In total, six out of seven test single cell samples were identified
with CNVs over 1 Mb or aneuploidies, including seven events of
CNVs from five samples and three events of aneuploidies from two
samples. Generally, the CNV results detected by our method were
highly consistent with confirmed CNV results (Table 2). For the
single-cell samples from PB or blastocysts, we successfully detected
the CNVs and aneuploidies using our method (Figure 3 & Table 2).
Especially, two smaller CNVs were also identified correctly in
samples SC 6 and SC 7 (Figure 4 & Table 2). The two CNVs were
a duplication of 3.94 Mb on chromosome 20 and a duplication of
Table 1. Sequencing data statistics.
Sample GC content (%) Reads number (M) Map rate (%) Coverage (%) Depth (X)
SC 1 39.47 14.64 62.69 4.20 0.15
SC 2 40.74 14.64 80.66 7.60 0.19
SC 3 39.43 7.13 79.16 4.00 0.09
SC 4 41.53 9.65 84.80 6.60 0.13
SC 5 40.93 8.69 82.39 6.10 0.12
SC 6 43.40 16.69 74.44 9.50 0.20
SC 7 43.69 15.50 72.95 7.70 0.18
YH-1 41.75 11.75 78.13 6.80 0.15
YH-2 41.59 14.32 77.18 5.90 0.18
doi:10.1371/journal.pone.0054236.t001
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5.47 Mb on chromosome 1. It indicates our method can identify
CNVs (.1 Mb) correctly and the detection results can reach
99.63% sensitivity and 97.71% specificity (Table 3).
To further estimate the sensitivity and specificity of our method
for CNVs detection on call level, we performed simulation in silico
to depict the relationship between CNVs size and its performance
(Materials and Methods). We first simulated CNVs, ranging from
500 kb to 5 Mb, on YH genome. Then, we applied our method to
evaluate the sensitivity and specificity of our method. Overall, the
sensitivity increased with the CNV size, and achieved about 94%
for CNV over 3 Mb could be detected successfully (Figure 5). Also
our method showed a high efficiency on decreasing the false
positive rate, for example, the specificity of 750 kb CNV was as
high as 95% (Figure 5). Additionally, we also studied our ability to
map breakpoints accurately by this simulation. For this purpose,
we calculated the minimum distance between the segmentation
algorithm (using about 10M simulated reads) predicted breakpoint
and the real breakpoint. The CNVs breakpoint precision analysis
indicated that we could localize the CNV breakpoints within about
70 kb (median), which was associated with the size of observation
windows.
Comparison with comparative genomic strategy
We also compared the methodology and practical performance
of our method with SegSeq [22,26], a well-recognized CNVs
detection method using short reads generated by massively parallel
sequencing. Different strategies were conducted to reduce the
significant influence of bias from WGA or sequencing procedure
in both methods. We removed GC bias by a weighted strategy
between observation (sequencing data) and expectation (the
average). To contrast, SegSeq used a comparative genomic
strategy to decrease the experimental variance between the case
and control, which is similar to the principle of array-CGH.
Another difference between two methods was the threshold
determination for final signals filtering, which is dynamic in our
method and fixed in SegSeq (Table 3).
We employed SegSeq to detect the CNVs in the seven test
samples with suggested parameters (-W 400 –a 1000 –b 10), using
the YH samples (YH-1 and YH-2) as control. A total of 16 CNVs
events were identified in seven samples, and also three additional
aneuploidies in two samples (Table 2). Almost all CNVs over
1 Mb were correctly detected in both methods, corresponding
99.63% and 92.75% of sensitivity for our method and SegSeq,
respectively. However, the specificity for SegSeq was only 16.49%
on CNVs larger than 1 Mb, which was far less than 97.71% of our
method (Table 3). Most of the false positive signals of SegSeq were
Figure 2. The comprehensive pipeline. This figure shows the
structure of the method in this study for CNVs identification, composed
of a sequencing reads alignment, GC bias correction, a binary
segmentation algorithm and dynamic threshold determination for
signals filtering.
doi:10.1371/journal.pone.0054236.g002
Figure 1. The distribution between RRN and Sequencing GC
content before and after GC correction. The distribution of relative
reads number (RRN, y-axis) and the corrected relative reads number
(CRN, y-axis) were exposed as boxplot maps respectively with their
sequencing GC content (x-axis).
doi:10.1371/journal.pone.0054236.g001
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common in GC-poor chromosomes (such as chromosome 13) and
GC-rich chromosomes (such as chromosome 19) (Figure S1),
which simply could not be filtered by a fixed threshold. These
signals could be explained by the significant GC bias in WGA
described above. Moreover, in the case of single cells with smaller
CNVs (Figure 4), our method showed a higher specificity for CNV
detection than SegSeq. For example, on chromosome 1 of SC 7, a
duplication of about 3 Mb on the cytogenetic band of p36
(24,736,617–27,719,432) was detected by SegSeq, but verified as a
false signal (Figure 4B).
In brief, our method based on a weighted strategy had more
efficient than the comparative genomics strategy to analyze CNVs
using WGA data, only for detection of CNVs over 1 Mb.
Figure 3. Performance of this method for test samples. This circular map shows the performance of our method on five single-cell samples
with CNVs and aneuploidies. The outermost circle depicts the bands of chromosomes 1, 2, 5, 11, 12, 13, 21. The inner circles represent the samples
SC1, SC2, SC3, SC4, and SC5. The color-coded dots represent the distribution of CRN, of which green and red show duplication and deletion,
respectively. The dark grey lines show the CNVs after segmentation.
doi:10.1371/journal.pone.0054236.g003
Table 2. Detected results of different methods for test single-cell samples.
sample Our method SegSeq WGS/SNP-Array
SC 1 46, XY, del(5)(p14.2Rpter), dup(12)(p13.1Rpter) 46,XY, del(1)(p36.11Rpter), del(5)(p14.3Rpter),
dup(12)(p13.1Rpter), dup(13)(q21.1 q32.1), del(19)(p13)
46, XY, del(5)(p14.2Rpter),
dup(12)(p13.1Rpter)
SC 2 47, XX, +21 47, XX, +21 47, XX, +21
SC 3 46, XY, dup(1)(q41Rqter), del(2)(q21.1Rqter) 46,XY, dup(1)(q41Rqter), del(2)(q14.3Rqter), del(19)(p13),
del(19)(q13.2 q13.33)
46,XY, dup(1)(q41Rqter),
del(2)(q14.3Rqter)
SC 4 46, XX, del(11)(q13.1 q25), 213, +21 46, XX, del(11)(q12.2Rqter), dup(19)(p13), 213, +21 46, XX, del(11)(q13Rqter), 213, +21
SC 5 46,XX 46,XX, dup(19)(p13) 46,XX
SC 6 46, XX, dup(20)(q13) 46, XX, dup(20)(q13), dup(19)(p13) 46, XX, dup(20)(q13)
SC 7 46, XX, dup(1)(p36.3) 46, XX, dup(1)(p36.3), dup(1)(p36.11) 46, XX, dup(1)(p36)
CNVs larger than 1 Mb in test samples were showed in this table.
doi:10.1371/journal.pone.0054236.t002
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Discussion
In this study, we developed a practical bioinformatics method to
detect CNVs at the single cell level through low coverage
massively parallel sequencing. The method consists of GC
correction, a binary segmentation algorithm and dynamic
threshold determination. With our correction strategy, more than
99.90% of WGA-induced GC biases, which hinders single-cell
CNVs analysis [18,20], were removed (Table S1), indicating a
high efficacy of GC correction. Finally, using the low coverage
sequencing (4,9.5%) data of test samples, our results were highly
consistent with confirmed results with 99.63% sensitivity and
97.71% specificity (Table 3).
However, several improvements are still necessary for further
studies. Firstly, our method shows a high false negative rate (FNR)
on smaller CNVs (,1 Mb) (Figure 5). Also, the simulation results
indicated that our sensitivity on smaller CNVs was strongly related
to the number of observation windows (Figure S2). Using smaller
observation windows could increase the sensitivity and improve
the resolution of our method. In addition, false positive signal in
smaller observation windows could be caused by the lack of data
from low coverage of whole genome sequencing. Therefore, it is
important for appropriate observation windows selection accord-
ing to data production and the sensitivity and resolution of our
method can also be improved by increasing the sequencing reads
or target sequencing [27] using smaller observation windows.
Secondly, except GC content, several factors, including chromo-
somal structure, repeat regions [18,19,20] etc., can also induce
WGA-bias. Ideally, these biases would mostly relate to specific
regions in human genome. Therefore, a population-scale normal-
ization strategy, comparing the same observation window with
data generated from the same batch, will be powerful for WGA-
induced bias removal.
Our method can be utilized for research on somatic CNVs to
explore cell evolution in cancers. Furthermore, it provides a
potential solution for CNVs detection in clinical applications of
single cell technology, such as PGD/PGS, using fetal nucleated
red blood cell for non-invasive prenatal diagnosis [12,13], or using
PB for identifying circulating tumor cells for fast and convenient
noninvasive cancer screening [28]. To meet these clinical needs,
more samples are necessary to improve the sensitivity and
specificity of our method. In conclusion, our method for CNVs
detection using WGA and MPS data highlights that CNVs
research at the single cell level and explores a potential solution for
single cell applications in clinic.
Materials and Methods
Overall design and concept
To develop an effective bioinformatics strategy for CNVs
detection at the single cell level through massively parallel
sequencing, we generated sequencing data using single cells
isolated from peripheral blood (PB) or blastocysts. The single cells
received a standard degenerate oligonucleotide primer PCR
(DOP-PCR) and Illumina sequencing at BGI-Shenzhen. After a
short read alignment, we first tried to describe the WGA-induced
bias. Considering the influence of the unique differences in the
human reference genome sequence, windows selection was
performed and well-selected windows were employed as the
minimum observation unit. We described the WGA-induced bias
using a relative reads number (RRN) and a newly defined statistic,
the GC-bias index (DRGC
2). Based on this significant discovery, we
developed a weighted correction strategy to lessen the influence of
WGA-induced bias. Finally, a bioinformatics pipeline, which
included GC correction for WGA-induced bias removal, a binary
segmentation algorithm for CNV breakpoints identification, and
dynamic threshold determination for a final signal filtering, was
established to access more accurate CNVs.
Table 3. Comparison between our method and SegSeq.
Methods Our method SegSeq
The core of methods Need a control (normal) sample No Yes
Correction or Normalization GC correction Normalization based on control sample
Segmentation algorithm Yes Yes
Final signals filtering by specific
method
Dynamic threshold determination
for final signals filtering
No
CNV identification for test samples * Sensitivity 99.63% 92.75%
Specificity 97.71% 16.49%
*CNVs larger than 1 Mb in test samples were used to calculate the sensitivity and specificity.
doi:10.1371/journal.pone.0054236.t003
Figure 4. Comparison between this method and SegSeq for
test samples. The figure below shows a comparison of our method’s
performance of CNVs identification and that of SegSeq’s. Figure A
shows the karyotype of chromosome 20 in single-cell sample SC 6 and
figure B shows the karyotype of part of chromosome 1 in single-cell
sample SC 7. The karyotypes were produced by our CNV identification
method (left), SegSeq (middle), and WGS (right). The color red, green,
dark gray and light gray represent deletion, duplication, N regions on
the genome, and normal regions, respectively.
doi:10.1371/journal.pone.0054236.g004
Copy Number Variation Analysis for Single Cell
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Sample recruitment, sample processing and single cell
isolation
A total of nine single cell samples from eight individuals were
collected at BGI-Shenzhen, CITIC Xiangya Reproductive &
Genetic Hospital, and Nanjing Maternal and Child Health
Hospital, including two from PB of YH with normal karyotype,
one from PB of an individual with Down’s syndrome, one from PB
of an individual with Cri-du-Chat (CDC) Syndrome, two from PB
of an individual with 1p duplication and 20q duplication, and
three trophectoderm cell samples from blastocysts. All those
samples were karyotyped by G-banding or FISH in local hospitals
before this study.
Each participant was recruited with informed written consent
and approval of the Institutional Review Board of BGI-Shenzhen,
for those trophectoderm samples the parents were also provided
informed consent under the protocol approved by the Ethics
Committee of the CITIC Xiangya Reproductive & Genetic
Hospital. For three of the participants less than five years old,
informed written consent was obtained from their guardians. All
the potential participants or their guardian were provided with the
detailed information of this study, including the benefits and risks
of our technology development in written information consent
form, and also were informed of the rights to privacy. The results
of this study would not feedback to the participants or their
guardian; therefore all potential participants or their guardian who
declined to participate or otherwise did not participate were
eligible for treatment and were not disadvantaged in any other
way by not participating in this study.
5–10 mL of PB was collected in EDTA-coated tubes at BGI.
10 ul blood samples for single cell isolation were frozen in 220uC.
The blood was thawed and washed with 500 ul of PBS with
centrifuged at 1,000 rpm for 10 minutes at room temperature.
The supernatant was discarded, and the nucleated cells were re-
suspended in PBS.
PBS with 5% BSA was used for droplet preparation in culture
dishes. We used mouth-controlled pipettes to transfer and dilute
the nucleated cells suspension in droplets under a microscope, and
isolated a single nucleated cell into 200 ul tubes containing 1.5 ul
of alkaline lysis buffer. The tubes with single cells were frozen in
280uC until further processing.
For blastocyst biopsies, the embryos expanded trophectoderm
(TE) protruding through the opened zona on day 5 or 6 were
chosen. Three to eight herniating TE cells were aspirated into the
lumen of a pipette (internal diameter: 30 mm) and detached from
the blastocyst by firing a laser at the area of constriction. They
were then washed several times in wash buffer and preserved in
200 ul PCR tubes.
Data generation and basic process
The single cells were amplified with the GenomePlex Single
Cell Whole Genome Amplification Kit (Sigma Aldrich) according
to the manufacturer’s instructions. The cell WGA was quality
controlled by PCR with primers for housekeeping genes including
PRDX6, RPL37a, ADD1, PSMD7, and ATP5O.
In total, two YH cells (YH-1 & YH-2), one T21 cell (SC 1), one
CDC cell (SC 2), two micro-duplication cells (SC 6 & SC 7) and
three single-cells from blastocysts (SC 3, SC 4, SC 5) were qualified
for further process in this study. After WGA, the products were
used to prepare a library of 350 bp insert size, and received whole
genome sequencing in Hiseq2000 platform with single-end (SE)
50 bp. All the raw sequencing data had submitted to NCBI SRA
(http://www.ncbi.nlm.nih.gov/sra) and the Submission ID is
SRA060638.
In the basic data process, reads after WGA-adapter removal
were mapped to the reference human genome (Hg18, Build36)
using SOAP2 [25] with maximum two mismatches [2v 2].
Afterwards, we removed low quality alignments, such as PCR
duplications (i.e. the identical reads) and non-unique alignments.
SNP array and Whole genome sequencing (WGS) analysis
To evaluate the performance of our method, we used two
different methods as gold standard, SNP array for single-cell
samples and WGS for peripheral blood (PB) samples.
Van et al. reported the SNP array analysis can identify CNVs as
small as 150 kb (.5 SNPs) for single cell [29]. Therefore, it is an
appropriate gold standard to compare the accuracy of detecting
CNV larger than 1-Mb in this study. For three single-cell samples
Figure 5. Evaluation of specificity and sensitivity for this method in silico. This figure shows the correlation between CNV size (x-axis) and
specificity and sensitivity (y-axis) of this method. The color-code lines represent the sensitivity (red) and specificity (blue), respectively.
doi:10.1371/journal.pone.0054236.g005
Copy Number Variation Analysis for Single Cell
PLOS ONE | www.plosone.org 6 January 2013 | Volume 8 | Issue 1 | e54236
(sample SC3 to SC5), SNP array analysis was conducted according
to the manufacturer’s instructions. Each DNA sample was
hybridized to the Gene Chip Mapping Nsp I 262K microarray
(Affymetrix Inc., Santa Clara, CA). Approximately 260,000 SNP
signal intensities for each test samples were compared computa-
tionally with averaged signals from 30 previously evaluated normal
female reference samples. Copy number analysis was performed
by Gene Chip Genotyping Analysis Software (GTYPE) with
default parameters to minimize the noise hybrid signals.
Derek et al. showed that WGS method can achieve a sensitivity
of approximately 100% when detected CNVs larger than 200-kb
using ,10M reads [22]. Thus, we employed WGS methods as
gold standards for PB samples to detect CNV larger than 1-Mb.
The rest six PB samples, including YH and the individuals with
Down’s syndrome, Cri-du-chat syndrome and two individuals with
micro duplication syndrome, were used for DNA extraction and
whole genome sequencing analysis with 350 bp insert size library
and single-end 50 bp sequencing in Illumina HiSeq2000 platform,
generating average 10M reads for each sample. The sequencing
data was mapped into the reference genome (Hg18, Build 36.3)
and non-unique mapped reads and PCR duplication were
removed. Then, we recruited these two YH samples as controls
to perform copy number analysis for the other four samples by
SegSeq (parameters: -W 400 –a 1000 –b 10) [22,26].
Windows selection
To lessen uncertain factors caused by data volume and
characteristics of the human reference genome, such as GC
content and uniqueness, we performed an optimized dynamic
observation windows selection. First, the average size of the
windows was determined by considering the GC content that is
characteristic of the human reference genome and our low
coverage sequencing strategy. Since it had been reported that long
DNA segments (.300 kb) have relatively homogeneous GC
content [30], the average size should be less than 300 kb to
access vivid GC content distribution for observation or correction.
However, the low coverage sequencing strategy (about 10 million
reads per sample) would lay more uncertain influence in smaller
genomic regions. Therefore, we decided to divide the human
genome into non-overlapping observation windows with an
average size of about 150 kb. Second, after considering unique-
ness, we performed a simulation to obtain the dynamic
observation windows. We divided the reference genome (HG18,
Build 36) into sliding SE50 simulated reads and mapped them to
the genome with a maximum of two mismatches and reserved
unique mapped reads. When constructing these windows, we
allowed the windows to share the same simulated reads numbers
instead of the same window size to achieve higher comparability of
suitable expected sequencing reads number among windows.
Finally, we got 18,743 observation windows, each sharing 140,000
simulated reads (Figure S3).
WGA GC bias description and correction
To describe the GC bias in WGA, we defined several statistics,
including the average sequencing GC content (gs), average
reference GC content (gr) and unique mapped reads (ri,j ) in each
window. Subscript i and j represent the different windows and
samples, respectively. The windows with no reads and zero GC
percent are ignored. Let Ri,j represents the relative reads number
(RRN), which is calculated by Ri,j~ri,j=M, where M is the global
average number of sequencing reads in each window on
autosomes. The effect of GC bias on the RRN was defined as
DRGC
2, which implied the average deviation between the
observed RRN to its expected, where DRGC
2 is calculated by
the following formula: DRGC
2~1{
sL
2
s2
,s2~
1
n
Xn
i~1
(Ri{M)
2,
sL
2~
1
n
Xn
i~1
(Ri{RL)
2, and RL represents the optimal prediction,
which was obtained via a loess regression fit of the relative reads
number (RRN) against the GC content, rounded to the nearest
0.5% increment. [22].
Based on this discovery, we developed a weighted correction
strategy in the following way. The sequencing reads within the
window i with GC content (gs and gr) were assigned with a weight
w~M= M, where M is the average number of sequencing reads in
each window which is calculated for every 1% GC content in
sequencing data (gs) and every 1% GC content in reference
genome (gr). Then, the corrected reads number (~ri,j ) in each
window was achieved with the following formula, ~ri,j~ri,j|w.
Afterwards, we defined the correction relative reads number
(CRN, ~Ri,j~~ri,j=M ’, where M ’ is the global average CRN) as the
normalized statistics for the following analysis.
Binary segmentation algorithm for CNVs breakpoints
identification
After removing the WGA-induced bias, we developed a binary
segmentation algorithm to detect CNVs breakpoints with low
coverage massively parallel sequencing. The binary segmentation
algorithm consisted of initialization and iterative merging between
adjacent segments.
Initialization. We calculated the significance of differences
between the two sides of each window with a run-test. Moreover,
100 CRNs were employed in the left and right side of each
window for difference significance statistics and each window was
assigned a p-value. Then, the 3,000 windows with minimal p-value
were selected as ordered initialized candidate breakpoints
(B~fb1,b2,b3,:::,bng).
Iterative merging between adjacent segments. Each
breakpoint bk was associated with a left segment from bk{1 to
bk, and a right segment from bk to bkz1 [22]. We estimated the
difference between the left and right segment of each window with
a run-test, where the p-value was denoted as pk. The candidate
breakpoint with the most insignificant difference (the largest p-
value) would be removed from B, indicating that segments of the
two sides of this breakpoint were merged. The iteration calculation
was performed until the p-value of each breakpoint was less than
the final p-value cutoff (pkvpcutoff ), where we choose the final p-
value cutoff (pcutoff ) from a control by the methods described
below.
Dynamic threshold determination for final signal filtering
To minimize the false signals and misdiagnosis of CNVs, we
defined a cutoff threshold for the average CRN between two
breakpoints after segmentation. Since the regions with same
sequencing GC content had similar variation trends in WGA,
based on central-limit theorem, we calculated the lower and upper
quantile (alpha = 0.05) of CRNs with the same sequencing GC
content as the deletion and duplication cutoff threshold respec-
tively.
Evaluation of sensitivity and specificity for test samples
To assess the efficacy of this method for CNVs detection, we
calculated the sensitivity and specificity through seven test samples
in the following way:
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sensitivity~LT=LC ; specificity~LT=L,
where L represents the total length of CNVs detected by this
method, LT represents the length of true CNVs detected by this
method, and LC represents the length of CNVs confirmed by
SNP-array or whole genome sequencing analysis.
Simulations and breakpoint precision analysis in silico
To get the overall sensitivity and specificity of our method on
call level, we performed a simulation on YH genome in silico. (I)
Candidate genomics region selection. We first filtered the N regions on
YH genome. Then we randomly selected regions as candidate
regions for further CNV simulation. To mimic the influence of YH
‘‘true CNVs’’ in further simulation, we analyzed these candidate
regions using WGS data of YH PB with SegSeq and excluded
those regions overlapped with ‘‘true CNVs’’ on YH genome. The
remained candidate regions would be used to CNVs simulation.
(II) CNV simulation. We then randomly simulated CNVs ranging
from 500 kb to 5 Mb based the candidate regions above on YH-1
and YH-2. We simulated totally 100 CNVs for each size. Under
the consideration of sequence volume, we extract 10M sequence
reads from YH-1 and YH-2 respectively. RRNs on selected
regions would multiply by 0.5 (deletion) or 1.5 (duplication)
directly. Standard GC correction, binary segmentation and
dynamic threshold determination were performed to detect these
simulated CNVs. (III) Sensitivity/specificity statistics and breakpoint
precision analysis. The sensitivity and specificity were calculated by
the following formula:
sensitivity~NT=N; specificity~NT=(NTzNF ),
where N , NT , NF represent the number of simulated CNVs (100),
true signals of CNVs and false signals of CNVs, respectively. Also,
we calculated the minimum distance between the predicted and
simulated CNV breakpoints to reveal the breakpoint precision of
our method.
Supporting Information
Figure S1 Comparison between this method and SegSeq
for test samples. The figure below shows a comparison of our
method’s performance of CNVs identification and that of SegSeq’s
and the distribution of RRNs and CRNs against GC content. The
part A & B show the karyotype of part of chromosome 5 and 19
and the part C & D show the distribution of RRNs and CRNs
against GC content in single-cell sample SC 1. The part E & F
show the karyotype of part of chromosome 1 and 13 and the part
G & H show the distribution of RRNs and CRNs against GC
content in single-cell sample SC 3. The karyotypes were produced
by our CNV identification method (left), SegSeq (right). The color
red, green, dark gray and light gray represent deletion,
duplication, N regions on the genome, and normal regions,
respectively. The black dots and green triangles on right figures
show the distribution of RRNs and CRNs against GC content on
genome and false positive region (on the chromosome 19 of SC 1
and the chromosome 13 of SC 3).
(TIF)
Figure S2 Evaluation of specificity and sensitivity for
this method by simulation. This figure shows the correlation
between CNV size (x-axis), the number of observation windows
(color-code lines) and performance (y-axis) of this method.
(TIF)
Figure S3 The distribution of observation window size.
This histogram shows the distribution of observation window size
using in this study. The x-axis and y-axis represent the window size
(bp) and frequency of the same window size, respectively.
(TIF)
Table S1 Effect of GC bias on the relative reads number (RRN).
(DOC)
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